Skip to main content
SpringerLink
Log in

Reply to letter to editor regarding: LHRH analog therapy is associated with worse metabolic side effects than bilateral orchiectomy in prostate cancer

  • Letter to the Editor
  • Published:
World Journal of Urology Aims and scope Submit manuscript

The Original Article was published on 25 February 2017

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Vargas A, Machado RD, Filho DI, Paiva CE, Dos Reis RB, Tobias-Machado M et al (2016) LHRH analog therapy is associated with worse metabolic side effects than bilateral orchiectomy in prostate cancer. World J Urol 34(12):1621–1628

    Article  CAS  PubMed  Google Scholar 

  2. Ostergren PB, Klausen TW, Fode M (2017) No convincing evidence on differences in metabolic effects of medical and surgical castration in the treatment of prostate cancer. World J Urol. https://doi.org/10.1007/s00345-017-2012-x

    PubMed  Google Scholar 

  3. Timilshina N, Hussain S, Breunis H, Alibhai SM (2011) Predictors of hemoglobin decline in non-metastatic prostate cancer patients on androgen deprivation therapy: a matched cohort study. Support Care Cancer 19(11):1815–1821

    Article  PubMed  Google Scholar 

  4. Hara N, Nishiyama T, Takizawa I, Saito T, Kitamura Y, Takahashi K (2010) Decline of the red blood cell count in patients receiving androgen deprivation therapy for localized prostate cancer: impact of ADT on insulin-like growth factor-1 and erythropoiesis. Urology. 75(6):1441–1445

    Article  PubMed  Google Scholar 

  5. Sun M, Choueiri TK, Hamnvik OP, Preston MA, De Velasco G, Jiang W et al (2016) Comparison of gonadotropin-releasing hormone agonists and orchiectomy: effects of androgen-deprivation therapy. JAMA Oncol 2(4):500–507

    Article  PubMed  Google Scholar 

  6. Chen DY, See LC, Liu JR, Chuang CK, Pang ST, Hsieh IC et al (2017) Risk of cardiovascular ischemic events after surgical castration and gonadotropin-releasing hormone agonist therapy for prostate cancer: a nationwide cohort study. J Clin Oncol 35(32):3697–3705

    Article  PubMed  Google Scholar 

  7. Bayoumi AM, Brown AD, Garber AM (2000) Cost-effectiveness of androgen suppression therapies in advanced prostate cancer. J Natl Cancer Inst 92(21):1731–1739

    Article  CAS  PubMed  Google Scholar 

  8. Seidenfeld J, Samson DJ, Aronson N, Albertson PC, Bayoumi AM, Bennett C et al (1999) Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer. Evid Rep/Technol Assess (Summary). 4:i-x

    Google Scholar 

  9. Clinical Trials website search. https://clinicaltrials.gov/ct2/results?cond=Prostate+Cancer&term=metabolic+syndrome%2C+orquiectomy%2C+analogue%2C+hormonal&cntry=&state=&city=&dist=

Download references

Author information

Authors and Affiliations

  1. Hospital de Cancer de Barretos, Barretos, Brazil

    Marcel Cabral Cognette, Andreza Vargas da Silva, Roberto Dias Machado & Eliney Ferreira Faria

Authors
  1. Marcel Cabral Cognette
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andreza Vargas da Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Roberto Dias Machado
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eliney Ferreira Faria
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marcel Cabral Cognette.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cognette, M.C., da Silva, A.V., Machado, R.D. et al. Reply to letter to editor regarding: LHRH analog therapy is associated with worse metabolic side effects than bilateral orchiectomy in prostate cancer. World J Urol 36, 683–684 (2018). https://doi.org/10.1007/s00345-018-2226-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-018-2226-6

Search

Navigation